PREoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation
Phase 2
- Conditions
- Hypoxemia (Defined by PaO2/FiO2( Fraction of Inspired Oxygen) Below 200)Adult PatientsRequiring IntubationPatient Covered by French Health Care System
- Registration Number
- NCT01782430
- Lead Sponsor
- University Hospital, Clermont-Ferrand
- Brief Summary
Prospective, randomized clinical multicentric study, in ICU, during preoxygenation for the intubation of hypoxemic patients.
- Detailed Description
Prospective randomized clinical multicentric study in ICU, comparing standard oxygenation, high flow nasal oxygen therapy and non invasive ventilation (NIV) , with pulse oxymetry values (SpO2), during preoxygenation for hypoxemic patients
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 132
Inclusion Criteria
- adults patients
- requiring intubation and hypoxemia (defined by PaO2/FiO2 below 200)
- patient covered by french health care system
Exclusion Criteria
- patient refusal
- intubation for other causes (excluding hypoxemia)
- impossibility to measure pulse oxymetry value
- contraindication for NIV : vomiting
- NIV intolerance
- cardiac arrest during intubation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method least pulse oxymetry value at day 1
- Secondary Outcome Measures
Name Time Method Partial pressure of arterial oxygen (PaO2) at day 1 oxyhemoglobin desaturation below 80 % at day 1 pulse oxymetry value (at the end of preoxygenation) at 5 minutes and at 30 minutes after intubation Regurgitation rate at day 1
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie improved oxygenation with high flow nasal oxygen in hypoxemic ICU patients?
How does non-invasive ventilation compare to standard oxygenation in preoxygenation for intubation in hypoxemic patients?
Which biomarkers predict response to high flow nasal oxygen therapy in PaO2/FiO2 < 200 ICU patients?
What are the adverse events associated with high flow nasal oxygen versus non-invasive ventilation in preoxygenation?
Are there combination therapies with high flow nasal oxygen that enhance preoxygenation efficacy in hypoxemic patients?
Trial Locations
- Locations (1)
CHU Clermont-Ferrand
🇫🇷Clermont-Ferrand, France
CHU Clermont-Ferrand🇫🇷Clermont-Ferrand, FrancePatrick LACARINContact04 73 75 11 95placarin@chu-clermontferrand.fr